[1]张博瀚,吴庆琛.FBXL20对人非小细胞肺癌A549细胞生长的影响[J].第三军医大学学报,2018,40(09):795-800.
 ZHANG Bohan,WU Qingchen.Effects of FBXL20 on proliferation in human non-small cell lung cancer A549 cells[J].J Third Mil Med Univ,2018,40(09):795-800.
点击复制

FBXL20对人非小细胞肺癌A549细胞生长的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第09期
页码:
795-800
栏目:
基础医学
出版日期:
2018-05-15

文章信息/Info

Title:
Effects of FBXL20 on proliferation in human non-small cell lung cancer A549 cells
作者:
张博瀚吴庆琛
重庆医科大学附属第一医院胸心外科
Author(s):
ZHANG Bohan WU Qingchen

Department of Cardiothoracic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

关键词:
FBXL20非小细胞肺癌增殖细胞周期
Keywords:
FBXL20 non-small cell lung cancer proliferation cell cycle
分类号:
R394.3; R730.23; R734.2
文献标志码:
A
摘要:

目的    观察FBXL20(F-box and leucine rich repeat protein 20)对人非小细胞肺癌A549细胞生长的影响并初步探究其机制。方法    采用慢病毒感染A549细胞,构建对照组(FBXL20-vector组)及干扰组(FBXL20RNAi组),通过Western blot验证慢病毒敲减效率。利用CCK-8及集落形成实验观察FBXL20的下调对A549细胞增殖能力的影响,流式细胞术检测细胞周期的变化,Western blot分析周期蛋白的改变,基因集富集分析(gene set enrichment analysis,GSEA)探究FBXL20可能参与的生物学过程。结果    干扰组FBXL20的蛋白表达(0.36±0.02)显著低于对照组(0.58±0.01)(P<0.01)。与对照组相比,干扰组的增殖能力增强(P<0.05),形成的集落数目也显著增加(100±20 vs 53±6)(P<0.05),且停留在G2/M期的细胞比例明显降低(5.65±1.35 vs 9.94±1.44)(P<0.05)。Western blot结果显示Cyclin D1、ERK1/2蛋白表达无明显变化(P>0.05),CDK2、Cyclin E、CDK1、Cyclin A、Cyclin B1蛋白表达显著增加,而p-ERK1/2则显著降低(P<0.05)。GSEA结果显示FBXL20的低表达与G2/M检查点呈正相关(P<0.01)。结论    下调FBXL20可以加快A549细胞G2/M期的进程,提高其生长能力。其机制可能是通过抑制p-ERK的激活,使得其下游周期蛋白CDK1、Cyclin A、Cyclin B1表达增加而实现的。

Abstract:

Objective    To detect the effect of F-box and leucine rich repeat protein 20 (FBXL20) on the proliferation of human non-small cell lung cancer A549 cells and mine the underlying mechanism. Methods    Lentiviral vector FBXL20-RNAi was used to transfect A549 cells to knock down the expression of FBXL20, and blank lentiviral vector (FBXL20-vector) was used for control cells. Knockdown efficiency was verified by Western blotting. CCK-8 assay and colony formation assay were used to determine the effects of silenced FBXL20 on the proliferation. Flow cytometry was performed to explore cell cycle alteration. Expression changes of cell cycle proteins were measured by Western blotting. Gene set enrichment analysis (GSEA) was conducted to investigate the biological process involved with FBXL20. Results    The protein level of FBXL20 was remarkably lower in the interference cells than the control cells (0.36±0.02 vs 0.58±0.01, P<0.01). Compared with the control cells, the interference cells had greater proliferation ability (P<0.05) and increased colony count (100±20 vs 53±6, P<0.05), and less cells arrested in G2/M phase (5.65±1.35 vs 9.94±1.44, P<0.05). Western blot results showed there were no significant differences in protein levels of Cyclin D1 and ERK1/2 (P>0.05), and the protein levels of CDK2, Cyclin E, CDK1, Cyclin A and Cyclin B1 were notably increased while p-ERK1/2 was distinctly decreased (P<0.05). GSEA revealed that low level of FBXL20 was positively correlated with G2/M checkpoint (P<0.01). Conclusion     Down-regulation of FBXL20 can expedite the G2/M phase of A549 cells and enhance the growth ability, which may due to the suppression of p-ERK activation, and therefore enhancement of the expression of its downstream cell cycle proteins CDK1, Cyclin A and Cyclin B1.

参考文献/References:

[1]SIEGEL R,NAISHADHAM D,JEMAL A. Cancer statistics, 2013[J]. CA,2013,63(1):11-30. DOI:10.3322/caac.21166.
[2]CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA,2016,66(2):115-132. DOI:10.3322/caac.21338.
[3]MOLINA J R,YANG P,CASSIVI S D,et al. Nonsmall cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J]. Mayo Clinic Proceedings,2008,83(5):584-594. DOI:10.4065/83.5.584.
[4]YAO I,TAKAGI H,AGETA H,et al. SCRAPPERdependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release[J]. Cell,2007,130(5):943-957. DOI:10.1016/j.cell.2007.06.052.
[5]牛静静,苗风济. siRNA靶向沉默fbxl20基因对肝癌SMMC7721细胞生物学行为的影响[J]. 川北医学院学报,2012,27(3):221-225. DOI:10.3969/j.issn.10053697.2012.03.007.
NIU J J,MIAO F J. Effect of siRNA targeted to fbxl20 on biological behavior of liver cancer SMMC7721 cells[J]. J North Sichuan Med Coll,2012,27(3):221-225. DOI:10.3969/j.issn.10053697.2012.03.007.
[6]朱晓华,邓世山,谢兴国,等. 结直肠腺癌发病基因fbxl20和Ecadherin的相关性研究[J]. 实用肿瘤学杂志,2013,28(6): 509-515. DOI:10.3969/j.issn.10023070.2013.06.007.
ZHU X H,DENG S S,XIE X G,et al. The research about correlation of colorectal adenocarcinoma gene fbxl20 and Ecadherin[J]. J Pract Oncology,2013,28(6):509-515. DOI:10.3969/j.issn.10023070.2013.06.007.
[7]ZHU J J,LI K,DONG L,et al. Role of FBXL20 in human colorectal adenocarcinoma[J]. Oncol Rep,2012,28(6):2290-2298. DOI:10.3892/or.2012.2065.
[8]ZHU J J,DENG S S,DUAN J,et al. FBXL20 acts as an invasion inducer and mediates Ecadherin in colorectal adenocarcinoma[J]. Oncol Lett,2014,7(6):2185-2191. DOI:10.3892/ol.2014.2031.
[9]EISFELD A K,MARCUCCI G,MAHARRY K,et al. miR3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia[J]. Blood,2012,120(2):249-258. DOI:10.1182/blood201202408492.
[10]温蓓,何刚. FBXL20在喉癌组织中的表达及意义[J]. 成都医学院学报,2016,11(6):706-708. DOI:10.3969/j.issn.16742257.2016.06.015.
WEN B,HE G. The expression and significance of FBXL20 in laryngeal carcinoma tissues[J]. J Chengdu Med Coll,2016,11(6):706-708. DOI:10.3969/j.issn.16742257.2016.06.015.
[11]高燕,林莉萍,丁健. 细胞周期调控的研究进展[J]. 生命科学,2005,17(4):318-322. DOI:10.3969/j.issn.10040374.2005.04.009.
GAO Y,LIN L P,DING J. A review: cell cycle regulation[J]. Chin Bull Life Sci,2005,17(4):318-322. DOI:10.3969/j.issn.10040374.2005.04.009.
[12]WOODS D, PARRY D, CHERWINSKI H, et al. Rafinduced proliferation or cell cycle arrest is determined by the level of raf activity with arrest mediated by p21Cip1[J]. Mol Cell Biol,1997,17(9):5598-5611. DOI:10.1128/MCB.17.9.5598.
[13]KARKHANIS M,PARK J. Sp1 regulates Raf/MEK/ERKinduced p21CIP1 transcription in TP53mutated cancer cells[J]. Cell Signall,2015,27(3):479-486. DOI:10.1016/j.cellsig.2015.01.005.
[14]WANG L,JIANG X,CHEN G, et al. Antitumor activity of SL4 against breast cancer cells:induction of G2/M arrest through modulation of the MAPKdependent p21 signaling pathway[J]. Sci Rep,2016,6:36486. DOI:10.1038/srep36486.
[15]LV C,SUN W, SUN H, et al. Asperolide A,a marinederived tetranorditerpenoid,induces G2/M arrest in human NCIH460 lung carcinoma cells,is mediated by p53p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway[J]. Marine Drugs, 2013, 11(2): 316-331. DOI:10.3390/md11020316.

相似文献/References:

[1]蒋娟,易亭伍,张瑜,等.非小细胞肺癌的肿瘤干细胞与非肿瘤干细胞中表皮生长因子受体基因异质性的研究[J].第三军医大学学报,2012,34(20):2039.
 Jiang Juan,Yi Tingwu,Zhang Yu,et al.Genetic heterogeneity of EGFR in cancer and non-cancer stem cells from non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(09):2039.
[2]杨庆羚,刘翩,王斌,等.EGFR-TKIs治疗晚期非小细胞肺癌并发间质性肺炎4例报告并文献复习[J].第三军医大学学报,2012,34(20):2060.
 Yang Qingling,Liu Pian,Wang Bin,et al.Interstitial pneumonia in EGFR-TKIs-treated non-small-cell lung cancer: report of 4 cases and review of the literature[J].J Third Mil Med Univ,2012,34(09):2060.
[3]斯晓燕,张力.西妥昔单抗联合化疗一线治疗非小细胞肺癌20例临床观察[J].第三军医大学学报,2012,34(20):2063.
 Si Xiaoyan,Zhang Li.Outcomes of cetuximab combined with chemotherapy as first line therapy in 20 patients with non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(09):2063.
[4]罗虎,罗丹,宫亮,等.联合CIK细胞与化疗对比单纯化疗治疗中晚期非小细胞肺癌的Meta分析[J].第三军医大学学报,2012,34(20):2119.
[5]张瑞萍,吴继华,黄英武,等.循环肿瘤细胞检测指导老年非小细胞肺癌个体化治疗1例[J].第三军医大学学报,2012,34(22):2248.
[6]闫霞,曹官铭,王导新.吉西他滨联合卡铂治疗老年非小细胞肺癌的临床评价[J].第三军医大学学报,2007,29(19):1913.
 YAN Xia,CAO Guan-min,WANG Dao-xin.Gemcitabine plus carboplatin regimen in treatment of advanced non-small cell lung cancer in aged patients[J].J Third Mil Med Univ,2007,29(09):1913.
[7]闵发胜,陈正堂.人非小细胞肺癌与外周血淋巴细胞表达LRP的相关性研究[J].第三军医大学学报,2007,29(17):1699.
 MIN Fa-sheng,CHEN Zheng-tang.Correlation between expression of lung resistance-related protein in non-small cell lung cancer and that in peripheral blood lymphocytes[J].J Third Mil Med Univ,2007,29(09):1699.
[8]高娟,饶进军,吴少瑜,等.丁酸钠与顺铂联用对非小细胞性肺癌细胞生长的抑制作用[J].第三军医大学学报,2007,29(11):1066.
 GAO Juan,RAO Jin-jun,WU Shao-yu,et al.Combination of sodium butyrate and cisplatin has antiproliferative effects on non-small lung cancer cell line[J].J Third Mil Med Univ,2007,29(09):1066.
[9]郑顺利,杨庆生,马小红.非小细胞肺癌患者纵隔淋巴结和外周血中MUC1基因的检测及意义[J].第三军医大学学报,2006,28(24):2472.
[10]张云嵩,范士志,王东,等.APE1在非小细胞肺癌中的表达特点及其与预后的关系[J].第三军医大学学报,2007,29(09):776.
 ZHANG Yun-song,FAN Shi-zhi,WANG Dong,et al.APE1 expression and its correlation with prognosis in non-small cell lung cancer[J].J Third Mil Med Univ,2007,29(09):776.

更新日期/Last Update: 2018-05-11